Telix Pharmaceuticals | TLX - EPS Earnings Per Share



Telix Pharmaceuticals reported AUD0.28 in EPS Earnings Per Share for its fiscal semester ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
Sep/2025 0.08 Oct/23 2025
FY2025H1 Jun/2025 0.02 0.27 0.09 Aug/20 2025
Mar/2025 0.06 Apr/22 2025
FY2024H2 Dec/2024 0.14 0.10 0.05 Feb/20 2025
FY2024H1 Jun/2024 0.09 0.15 Aug/21 2024
FY2023H2 Dec/2023 0.05 0.05 -0.10 Feb/22 2024
FY2023H1 Jun/2023 -0.05 0.06 -0.23 Jul/19 2023
FY2022H2 Dec/2022 -0.10 -0.05 -0.17 Feb/27 2023
FY2022H1 Jun/2022 -0.23 -0.10 -0.12 Aug/18 2022
FY2021H2 Dec/2021 -0.17 -0.10 Jan/24 2022
FY2021H1 Jun/2021 -0.12 -0.10 -0.07 Aug/19 2021
FY2020H2 Dec/2020 -0.10 -0.07 Feb/26 2021


Eps Change Date
Cochlear AUD 3.13 0.17 Dec/2024
CSL USD 4.27 2.44 Dec/2024
Integral Diagnostics AUD 0.04 0.01 Dec/2024
Mayne Pharma AUD -0.89 0.64 Jun/2025
Medical Developments International AUD 0 0.34 Dec/2024
Mesoblast USD -0.04 0 Jun/2025
Neuren Pharmaceuticals AUD 1.02 0.96 Dec/2024
Pacific Edge NZD -0.02 0 Sep/2024
Paradigm Biopharmaceuticals -0.02 0.01 Dec/2024
Polynovo AUD 0.01 0 Jun/2025
PYC Therapeutics AUD -0.06 0 Dec/2024
Ramsay Health Care AUD 0.52 0.13 Dec/2025
ResMed USD 2.58 2.33 Jun/2025
Sonic Healthcare AUD 0.57 0.08 Jun/2025